-
ESMO 2024丨Dr. Jakob N. Kather: Does Artificial Intelligence Have a Place in Precision Oncology?
The strength of artificial intelligence (AI) in precision oncology lies in its ability to unlock the value of real-world data from millions of cancer patients. In recent years, AI has empowered oncologists to analyze large datasets from multiple sources, including next-generation sequencing and medical imaging, aiding in cancer characterization and offering a more comprehensive understanding…
-
Dr. Xiangdong Cheng: Prioritizing Patient Needs to Foster Original, China-Specific Research in Gastric Cancer丨CACA Integrative Gastric Cancer
On October 18-19, 2024, the CACA Integrative Gastric Cancer Conference was held in Wuhan, bringing together multidisciplinary experts from around the world to discuss the latest advances, standards, and research developments in gastric cancer diagnosis and treatment.During the conference, Oncology Frontier interviewed Dr. Xiangdong Cheng, Secretary of Zhejiang Cancer Hospital. Professor Cheng shared insights into…
-
ESMO 2024丨Dr. Xiaojie Bian: Optimizing mCRPC Treatment Strategies and Prognostic Analysis Through Biomarkers
For most prostate cancer patients, resistance to androgen deprivation therapy (ADT) inevitably develops within 18-36 months, progressing to castration-resistant prostate cancer (CRPC). This transition not only increases mortality risk but also poses a serious challenge to survival outcomes. The European Society for Medical Oncology (ESMO) Annual Meeting 2024, held from September 13 to 17 in…
-
Welcome to 2024 Chinese Congress of Holistic Integrative Oncology (2024 CCHIO) & 4th International Congress of the Asian Oncology Society (AOS2024)
On behalf of the organizing committee of the 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO), we are very pleased to invite you to attend the 2024 CCHIO & 4th International Congress of the Asian Oncology Society (AOS2024) . This esteemed event will be held from November 14-16, 2024, in the historic and culturally rich…
-
CGCA New Chairman Dr. Lin Chen: Moving Forward, Amplifying China’s Voice on the Global Stage丨2024 CACA Integrated Gastric Cancer Conference
On October 18-19, 2024, the CACA Integrated Gastric Cancer Conference concluded successfully in Wuhan, gathering global authorities in gastric cancer to discuss the latest advancements, pioneering developments, and standardized protocols for gastric cancer treatment. During the event, the Chinese Anti-Cancer Association Gastric Cancer Professional Committee (CGCA) completed its transition, electing Dr. Lin Chen from Peking…
-
ESMO 2024丨Dr. Tao Sun: New Breakthroughs in First-Line Treatment of Advanced TNBC with Anlotinib, Penpulimab, and Nab-Paclitaxel
The 2024 European Society for Medical Oncology (ESMO) Annual Meeting is taking place from September 13-17 in Barcelona, Spain. Dr. Tao Sun from Liaoning Cancer Hospital is leading a prospective phase II study, which will be presented as a poster at the conference (Poster Abstract No. 387P). This study explores the efficacy and safety of…
-
Dr. Ying Han: Early Diagnosis and Intervention Strategies for Refractory Primary Biliary Cholangitis
Diagnosis and Treatment of PBC PBC is a chronic autoimmune intrahepatic cholestatic disease that predominantly affects middle-aged and older women, characterized by progressive intrahepatic bile duct injury and elevated anti-mitochondrial…
-
Dr. Yong Song: Balancing Risks and Benefits of Radiotherapy and Immunotherapy for Optimal Clinical Outcomes
Recently, the “Expert Consensus on Radiotherapy Combined with Immunotherapy for Unresectable Lung Cancer (2024 Edition)” was published, co-authored by Academician Jinming Yu of Shandong Cancer Hospital, Professor Ying Cheng of Jilin Cancer Hospital, and Professor Liangan Chen of the Chinese People’s Liberation Army General Hospital. This publication marks a new level of scientific standardization in…
Connecting Medical Expertise through Media